NASDAQ:RMTI - Rockwell Medical Stock Price, Price Target & More

Get Started

$5.94 0.00 (0.00 %)

(As of 05/25/2018 07:23 AM ET)

Previous Close$5.94

Today's Range$5.94 - $5.94

52-Week Range$4.84 - $8.70

Volume7,760 shs

Average Volume188,764 shs

Market Capitalization$307.50 million

P/E Ratio-11.65

Dividend YieldN/A

Beta2.18

About Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNASDAQ:RMTI

CUSIP77437410

Webwww.rockwellmed.com

Phone248-960-9009

Debt

Debt-to-Equity RatioN/A

Current Ratio5.25

Quick Ratio4.23

Price-To-Earnings

Trailing P/E Ratio-11.65

Forward P/E Ratio-15.63

P/E GrowthN/A

Sales & Book Value

Annual Sales$57.30 million

Price / Sales5.37

Cash FlowN/A

Price / CashN/A

Book Value$0.53 per share

Price / Book11.21

Profitability

EPS (Most Recent Fiscal Year)($0.51)

Net Income$-25,920,000.00

Net Margins-48.06%

Return on Equity-76.49%

Return on Assets-45.06%

Miscellaneous

Employees300

Outstanding Shares51,770,000

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) issued its earnings results on Thursday, May, 10th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.14) by $0.01. The company earned $14.95 million during the quarter. Rockwell Medical had a negative net margin of 48.06% and a negative return on equity of 76.49%. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

1 brokers have issued 1-year price targets for Rockwell Medical's stock. Their forecasts range from $11.00 to $11.00. On average, they anticipate Rockwell Medical's stock price to reach $11.00 in the next twelve months. View Analyst Ratings for Rockwell Medical.

Who are some of Rockwell Medical's key competitors?

Some companies that are related to Rockwell Medical include Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Fonar (FONR), Second Sight Medical Products (EYES), Biolife Solutions (BLFS), Zynex (ZYXI), IRIDEX (IRIX), Edap Tms (EDAP), Semler Scientific (SMLR), BioSig Technologies (BSGM), Viveve Medical (VIVE) and Stereotaxis (STXS).

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:

Mr. Robert L. Chioini, Founder & CEO (Age 53)
Mr. Thomas E. Klema CPA, MBA, Chief Financial Officer, VP of Fin., Treasurer and Sec. (Age 64)
Dr. Ajay Gupta M.D., Chief Scientific Officer and Member of Scientific Advisory Board (Age 60)
Dr. Raymond Dennis Pratt M.D., FACP, Chief Medical Officer (Age 67)

Has Rockwell Medical been receiving favorable news coverage?

Headlines about RMTI stock have been trending somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Rockwell Medical earned a daily sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 45.89 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include RICHMOND BROTHERS, INC. (10.80%) and Schwab Charles Investment Management Inc. (0.19%). Company insiders that own Rockwell Medical stock include David S Richmond and Kenneth L Holt. View Institutional Ownership Trends for Rockwell Medical.

Which major investors are buying Rockwell Medical stock?

RMTI stock was acquired by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Rockwell Medical.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $5.94.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $307.50 million and generates $57.30 million in revenue each year. The company earns $-25,920,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis. Rockwell Medical employs 300 workers across the globe.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]

MarketBeat Community Rating for Rockwell Medical (RMTI)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		196 (Vote Outperform)
Underperform Votes:		222 (Vote Underperform)
Total Votes:		418

MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Rockwell Medical (NASDAQ:RMTI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

1 Wall Street analysts have issued ratings and price targets for Rockwell Medical in the last 12 months. Their average twelve-month price target is $11.00, suggesting that the stock has a possible upside of 85.19%. The high price target for RMTI is $11.00 and the low price target for RMTI is $11.00. There are currently 1 strong buy rating for the stock, resulting in a consensus rating of "Strong Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Strong Buy	Strong Buy	Strong Buy	Strong Buy
Consensus Rating Score:	4.00	4.00	4.00	4.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)
Consensus Price Target:	$11.00	$11.00	$11.00	$11.00
Price Target Upside:	85.19% upside	76.28% upside	76.28% upside	76.28% upside

Rockwell Medical (NASDAQ:RMTI) Consensus Price Target History

Price Target History for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
8/14/2017	Ifs Securities	Initiated Coverage	Strong-Buy	$11.00	Medium
11/9/2016	BTIG Research	Reiterated Rating	Buy	$12.00	N/A
11/8/2016	Bank of America	Downgrade	Neutral ➝ Underperform	$9.00 ➝ $5.00	N/A

(Data available from 5/25/2016 forward)

Rockwell Medical (NASDAQ:RMTI) Earnings History and Estimates Chart

Earnings by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.38 EPS
Next Year EPS Consensus Estimate: $0.04 EPS

Rockwell Medical (NASDAQ RMTI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/7/2018		($0.15)					N/A
5/10/2018	Q1 2018	($0.14)	($0.13)		$14.95 million	View	N/A
3/15/2018	Q4 2017	($0.13)	($0.18)	$13.20 million	$14.84 million	View	Listen
11/8/2017	Q3 2017	($0.10)	($0.0960)	$13.33 million	$14.63 million	View	N/A
8/9/2017	Q2 2017	($0.10)	($0.14)	$13.05 million	$13.24 million	View	Listen
5/9/2017	Q1 2017	($0.09)	($0.09)	$12.66 million	$14.60 million	View	Listen
3/15/2017	Q4 2016	($0.09)	($0.10)	$15.45 million	$13.39 million	View	N/A
11/7/2016	Q3	($0.10)	($0.09)	$15.40 million	$12.81 million	View	Listen
8/8/2016	Q2	($0.10)	($0.11)	$13.86 million	$12.50 million	View	N/A
5/10/2016	Q1	($0.08)	($0.10)	$15.25 million	$13.63 million	View	Listen
2/29/2016	Q4	$0.02	($0.12)	$19.98 million	$14.10 million	View	Listen
11/9/2015	Q315	($0.02)	($0.05)	$14.93 million	$14.40 million	View	Listen
8/4/2015	Q215	($0.10)	($0.05)	$11.84 million	$12.96 million	View	Listen
5/7/2015	Q414	($0.10)	($0.07)	$13.20 million	$13.90 million	View	N/A
2/26/2015	Q4	($0.10)	($0.14)	$13.51 million	$14.40 million	View	N/A
11/10/2014	Q314	($0.10)	($0.10)	$13.40 million	$13.70 million	View	N/A
7/31/2014	Q2	($0.13)	($0.08)	$13.45 million	$13.00 million	View	N/A
5/12/2014	Q1	($0.14)	($0.20)	$14.22 million	$13.00 million	View	N/A
2/26/2014		($0.28)	($0.21)	$14.11 million	$13.97 million	View	N/A
11/5/2013	Q3 2013	($0.22)	($0.34)	$13.90 million	$13.09 million	View	N/A
8/1/2013	Q2 2013	($0.31)	($0.38)	$13.58 million	$12.98 million	View	N/A
5/8/2013	Q1 2013	($0.34)	($0.72)	$13.11 million	$12.34 million	View	N/A
3/18/2013	Q4 2012	($0.44)	($0.66)			View	N/A
11/8/2012	Q312	($0.50)	($0.86)	$12.57 million	$12.70 million	View	N/A
8/7/2012	Q2 2012	($0.48)	($0.58)			View	N/A
5/3/2012	Q1 2012	($0.43)	($0.54)			View	N/A
3/1/2012	Q4 2011	($0.17)	($0.49)			View	N/A
11/3/2011	Q3 2011	($0.25)	($0.28)			View	N/A
8/4/2011	Q2 2011	($0.20)	($0.26)			View	N/A
5/5/2011	Q1 2011	($0.14)	($0.17)			View	N/A
3/3/2011	Q4 2010	($0.06)	($0.10)			View	N/A
11/4/2010	Q3 2010	($0.02)	($0.04)			View	N/A
8/5/2010	Q2 2010	($0.04)	$0.01			View	N/A
5/5/2010	Q1 2010	($0.06)	($0.02)			View	N/A
3/10/2010	Q4 2009	($0.06)	($0.03)			View	N/A
11/4/2009	Q3 2009	($0.11)	($0.11)			View	N/A
8/10/2009	Q2 2009		($0.12)			View	N/A
5/11/2009	Q1 2009		($0.12)			View	N/A
3/16/2009	Q4 2008		($0.22)			View	N/A
11/13/2008	Q3 2008		($0.18)			View	N/A
8/12/2008	Q2 2008		($0.08)			View	N/A
5/7/2008	Q1 2008		($0.09)			View	N/A
3/6/2008	Q4 2007		($0.01)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Rockwell Medical (NASDAQ:RMTI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Rockwell Medical (NASDAQ RMTI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.21%

Insider Trading History for Rockwell Medical (NASDAQ:RMTI)

Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ RMTI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2017	David S Richmond	Insider	Sell	36	$6.53	$235.08	176,376
3/22/2017	David S Richmond	Insider	Buy	37,210	$5.84	$217,306.40	176,412
3/16/2017	Kenneth L Holt	Director	Sell	6,000	$5.98	$35,880.00	17,430
11/11/2016	Kenneth L Holt	Director	Sell	19,725	$5.16	$101,781.00	32,355
11/1/2016	Kenneth L Holt	Director	Sell	1,400	$5.92	$8,288.00	38,355
10/21/2016	Kenneth L Holt	Director	Sell	2,533	$6.04	$15,299.32	41,338
9/19/2016	Kenneth L Holt	Director	Sell	8,075	$6.81	$54,990.75	46,858
8/25/2016	Kenneth L Holt	Director	Sell	9,520	$6.37	$60,642.40	56,048
8/16/2016	Kenneth L Holt	Director	Sell	3,692	$7.31	$26,988.52	63,475
12/4/2015	Ronald D. Boyd	Director	Sell	12,500	$10.58	$132,250.00	32,500
8/14/2015	Robert L Chioini	CEO	Buy	4,910	$11.96	$58,723.60
8/13/2015	Raymond Dennis Pratt	VP	Buy	5,000	$11.54	$57,700.00
8/13/2015	Robert L Chioini	CEO	Buy	5,090	$11.51	$58,585.90
8/27/2012	David A Hagelstein	Major Shareholder	Buy	7,000	$8.10	$56,700.00

(Data available from 1/1/2013 forward)

Rockwell Medical (NASDAQ RMTI) News Headlines

Source:

Date	Headline
	Investor Alert: Kaplan Fox Announces Investigation Of Rockwell Medical www.prnewswire.com - May 24 at 7:31 PM
	Rockwell Medical Inc (RMTI) Expected to Announce Earnings of -$0.13 Per Share www.americanbankingnews.com - May 24 at 7:20 PM
	BRIEF-Rockwell Medical Announces CEO Transition www.reuters.com - May 24 at 5:44 PM
	RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc ... www.businesswire.com - May 24 at 5:44 PM
	Rockwell Medical announces CEO transition; shares ahead 9% premarket seekingalpha.com - May 24 at 5:44 PM
	Glancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. Investors www.businesswire.com - May 24 at 5:44 PM
	BRIEF-Rockwell Medical Says Independent Directors Determined CEO Termination Not Effective www.reuters.com - May 24 at 5:44 PM
	Bragar Eagel & Squire, PC is Investigating Rockwell Medical, Inc. (RMTI) on Behalf of Stockholders and Encourages ... www.businesswire.com - May 24 at 5:44 PM
	Company Isn’t Sure If It Fired Its CEO finance.yahoo.com - May 24 at 5:44 PM
	ROCKWELL MEDICAL, INC. INVESTOR ALERT: Girard Gibbs Announces Investigation on Behalf of RMTI Investors finance.yahoo.com - May 24 at 5:44 PM
	Rockwell Medical Issues Statement finance.yahoo.com - May 24 at 5:44 PM
	EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Rockwell Medical, Inc. - RMTI finance.yahoo.com - May 24 at 5:44 PM
	Glancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. Investors finance.yahoo.com - May 24 at 5:44 PM
	Bragar Eagel & Squire, P.C. is Investigating Rockwell Medical, Inc. (RMTI) on Behalf of Stockholders and Encourages Investors to Contact the Firm finance.yahoo.com - May 24 at 5:44 PM
	Nasdaq Scheduled Resumption in Rockwell Medical, Inc. finance.yahoo.com - May 24 at 5:44 PM
	RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc. Investors www.bizjournals.com - May 24 at 8:18 AM
	RMTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Rockwell Medical, Inc. Investors finance.yahoo.com - May 24 at 8:18 AM
	Nasdaq Halts Rockwell Medical, Inc. finance.yahoo.com - May 23 at 5:37 PM
	Blood Cleaning Co's Ousted CEO Denies Exit in Filing Faceoff finance.yahoo.com - May 23 at 5:37 PM
	Rockwell Medical CEO Issues Press Release finance.yahoo.com - May 23 at 5:37 PM
	Rockwell Medical Announces CEO Transition finance.yahoo.com - May 23 at 8:17 AM
	Rockwell Medical (RMTI) Cut to Sell at Zacks Investment Research www.americanbankingnews.com - May 17 at 4:19 PM
	Stock Traders Buy High Volume of Put Options on Rockwell Medical (RMTI) www.americanbankingnews.com - May 15 at 6:48 AM
	Implied Volatility Surging for Rockwell Medical (RMTI) Stock Options www.zacks.com - May 14 at 8:24 AM
	Comparing Rockwell Medical (RMTI) and NxStage (NXTM) www.americanbankingnews.com - May 12 at 5:17 AM
	Rockwell Medical (RMTI) Posts Earnings Results www.americanbankingnews.com - May 11 at 4:54 PM
	Rockwell Medical's (RMTI) CEO Rob Chioini on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 11 at 8:22 AM
	Edited Transcript of RMTI earnings conference call or presentation 10-May-18 8:30pm GMT finance.yahoo.com - May 11 at 8:22 AM
	Rockwell Medical Reports First Quarter 2018 Results finance.yahoo.com - May 10 at 5:59 PM
	Rockwell Medical: 1Q Earnings Snapshot finance.yahoo.com - May 10 at 5:59 PM
	3 Things In Biotech, May 9: New AML Therapy Imminent? AVEO Hedges, Rockwell Boosts Iron seekingalpha.com - May 10 at 8:20 AM
	Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA finance.yahoo.com - May 8 at 5:41 PM
	Rockwell Medical (RMTI) Expected to Post Earnings of -$0.13 Per Share www.americanbankingnews.com - May 7 at 11:22 AM
	Rockwell Medical Schedules First Quarter 2018 Earnings Call feeds.benzinga.com - May 2 at 11:58 AM
	Rockwell Medical (RMTI) Scheduled to Post Quarterly Earnings on Monday www.americanbankingnews.com - April 30 at 9:57 AM
	Analysts Expect Rockwell Medical Inc (RMTI) to Post -$0.13 EPS www.americanbankingnews.com - April 20 at 9:18 AM
	Rockwell Medical (RMTI) Upgraded to "Sell" at BidaskClub www.americanbankingnews.com - April 10 at 7:19 PM
	Active-Investors: Blog Exposure - Impax Launched a Generic Version of Estrace(R) Cream www.finanznachrichten.de - April 10 at 5:31 PM
	Does Rockwell Medical Inc (NASDAQ:RMTI) Go Up With The Market? finance.yahoo.com - April 10 at 5:31 PM
	Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings globenewswire.com - April 7 at 4:34 PM
	Rockwell Medical (RMTI) Lifted to "Buy" at Zacks Investment Research www.americanbankingnews.com - April 5 at 4:38 PM
	Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings finance.yahoo.com - April 5 at 10:08 AM
	Zacks: Brokerages Anticipate Rockwell Medical Inc (RMTI) to Announce -$0.13 Earnings Per Share www.americanbankingnews.com - April 3 at 11:33 AM
	Rockwell Medical Sees Unusually Large Options Volume (RMTI) www.americanbankingnews.com - March 28 at 6:44 AM
	Rockwell Medical (RMTI) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - March 27 at 2:54 PM
	Rockwell Medical (RMTI) & Edap Tms (EDAP) Financial Survey www.americanbankingnews.com - March 22 at 11:12 PM
	Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology - GlobeNewswire (press release) globenewswire.com - March 21 at 8:44 AM
	Wired News – Pfizer Signs Collaboration Deal with BioDuro to Develop Shelf-Stable Fluorosulfation Reagent finance.yahoo.com - March 21 at 8:44 AM
	Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology finance.yahoo.com - March 20 at 5:19 PM
	Rockwell Medical (RMTI) Raised to "Hold" at BidaskClub www.americanbankingnews.com - March 18 at 4:58 PM

Rockwell Medical (NASDAQ:RMTI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Rockwell Medical (NASDAQ:RMTI) Income Statement, Balance Sheet and Cash Flow Statement

Rockwell Medical (NASDAQ RMTI) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff